Medications

FDA approves Regeneron's eye injection Eylea

(AP) -- Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people.

Medical research

Controversial research on bird flu

In a top-security lab in the Netherlands, scientists guard specimens of a super-killer influenza that slays half of those it infects and spreads easily from victim to victim.

Genetics

UK drops DNA tests for refugees and asylum seekers

(AP) -- Britain has dropped a controversial policy of using DNA tests to identify the nationality of African refugees and asylum seekers after criticism that there is no scientific merit to the practice.

Medications

FDA panel unanimously backs Regeneron eye drug

(AP) -- A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.

Medical research

Bird flu debate: Should H5N1 experiments resume?

Virologists making mutated versions of the H5N1 bird flu halted their research in January after a U.S. government advisory panel suggested that their work, though well-intentioned, had the potential to endanger the public.

page 1 from 4